ArticleAdvances in therapy2026

Summary of Research: Brentuximab Vedotin and Nivolumab in Combination with Chemotherapy for Nonbulky, Early-Stage Classical Hodgkin Lymphoma.

Jeremy S Abramson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.